Neuro-ophthalmology is a challenging area that incorporates many conditions that affect the neurological control of the visual system, such as strabismus and optic neuritis. Management often requires a multidisciplinary approach involving ophthalmology and neurology specialists.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
In this Expert Pearl, Dr Ashwini Kini shares practical expertise to guide healthcare providers in identifying common neuro-ophthalmic emergencies, recognising key red flag symptoms and signs, and understanding when and to whom to refer, as well as the urgency of referral. With a clear overview of the expected work-up required to diagnose and treat underlying causes in a timely manner, this short article aims to support first-line clinicians, including primary care physicians and optometrists, in preventing irreversible visual loss and long-term disability, as well as serious systemic complications.
Three experts examine neural tear pathways and evidence-based integration of neural-targeted DED therapies.
The Artemis II mission successfully returned to Earth on April 10, 2026. While the crew begins the physical process of readjusting to Earth’s gravity, the ophthalmic community is just starting its deep dive into the most significant ocular data set in over half a century. This mission represents more than a milestone in exploration; it serves as a high-stress incubator for the human visual system. By removing the constant of Earth's gravity and exposing human tissue to the deep-space environment, NASA is helping us solve complex physiological mysteries that have direct implications for our patients on the ground. From neuro-ophthalmic pressure gradients to the resilience of the corneal surface, this research is reshaping our clinical understanding of the eye.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
A leading dry eye disease expert discusses the pathophysiology, diagnostic tools, and current and emerging treatments.
A neurologist and a neuro-ophthalmologist discuss best practices for early diagnosis and treatment of NMOSD
Mydriasis physiology Mydriasis refers to physiologic or pharmacologic pupillary dilation. Physiologic pupillary dilation occurs naturally as a response to low light and viewing objects in the distance. This process is mediated by both the iris sphincter and the iris dilator ...
Watch specialists in neurological disorders share their insights on the role of complement and complement therapeutics in patients with neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG).
Three experts examine evidence-based approaches for early and accurate diagnosis, appropriate treatment selection and patient-centred care to mitigate the clinical burden of neuromyelitis optica spectrum disorder.
Leber hereditary optic neuropathy (LHON) is a mitochondrially inherited optic nerve disease characterized by bilateral (sequential or simultaneous), subacute, painless central vision loss.1 LHON was first described in 1871 by the German ophthalmologist Theodor Leber.2 However, it was not until 1988 that ...
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.